Christina Kober
AventuSoft (United States)(US)
Publications by Year
Research Areas
Virus-based gene therapy research, CAR-T cell therapy research, Cancer, Stress, Anesthesia, and Immune Response, Immune cells in cancer, interferon and immune responses
Most-Cited Works
- → Inactivating CUX1 mutations promote tumorigenesis(2013)140 cited
- → Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy(2023)70 cited
- → IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools(2022)44 cited
- → Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps(2015)25 cited
- → Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors(2021)21 cited
- → Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent(2015)20 cited
- → Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer(2013)19 cited
- → Abstract 4454: Identification of BAY-218, a potent and selective small-molecule AhR inhibitor, as a new modality to counteract tumor immunosuppression(2019)14 cited
- → Acute seronegative polyarthritis associated with lymphogranuloma venereum infection in a patient with prevalent HIV infection(2011)13 cited
- → Abstract 1288: Blocking tumor-associated immune suppression with BAY-218, a novel, selective aryl hydrocarbon receptor (AhR) inhibitor(2019)13 cited